Venture Capitalists’ Selection Process: The Case of Biotechnology Proposals
The paper analyses venture capitalists’ selection process in biotechnology ventures. Despite the higher risk of biotech investments, the authors find no evidence that VCs require higher hurdle rates or more complete contracts for these investments, compared to investments in other technology-based companies.
Geography
Link
http://www.FEB.UGent.be/fac/research/WP/Papers/wp_05_313.pdf